Allogene Therapeutics Announces Participation in Upcoming Investor Conferences May 26, 2026 08:30AM
Allogene Therapeutics closes $200.4 million stock offering Apr 16, 2026 04:01PM
Allogene Therapeutics Announces Closing of $200.4 Million Public Offering of Common Stock Apr 16, 2026 04:01PM
Allogene prices $175 million stock offering at $2 per share Apr 14, 2026 09:50PM
Allogene Therapeutics Announces Pricing of Public Offering of Common Stock Apr 14, 2026 09:50PM


Apr 13, 2026 04:01PM Allogene announces $175 million public stock offering
Apr 13, 2026 04:01PM Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock
Feb 5, 2026 08:30AM Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
Nov 10, 2025 08:30AM Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
May 23, 2025 08:30AM Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
Feb 26, 2025 08:30AM Allogene Therapeutics Announces Participation in March Investor Conference
May 23, 2024 08:30AM Allogene Therapeutics Announces Participation in the TD Cowen 5th Annual Oncology Innovation Summit
Feb 28, 2024 08:30AM Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
Oct 30, 2023 08:30AM Allogene Therapeutics Announces Participation in November Investor Conferences
Sep 5, 2023 07:00AM Cantor Fitzgerald Bolsters Healthcare and Biotechnology Equity Research Team with Addition of Josh Schimmer, M.D., and Eric Schmidt, Ph.D.
May 24, 2023 08:30AM Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences
Mar 2, 2023 08:30AM Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
Mar 2, 2023 08:30AM Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
Nov 9, 2022 08:30AM Allogene Therapeutics To Host Research & Development Showcase and Participate in Five Upcoming Investor Conferences
Nov 9, 2022 08:30AM Allogene Therapeutics To Host Research & Development Showcase and Participate in Five Upcoming Investor Conferences
Feb 24, 2022 05:31AM Cowen Reiterates Outperform Rating on Allogene (ALLO), "We Recommend Accumulating ALLO Shares"
Jan 26, 2022 08:30AM Allogene Therapeutics Announces Participation in Four Upcoming Virtual Investor Conferences
Jan 26, 2022 08:30AM Allogene Therapeutics Announces Participation in Four Upcoming Virtual Investor Conferences
Dec 13, 2021 08:35AM Allogene (ALLO) Named Best 2022 Idea at Cowen
Dec 13, 2021 05:49AM Cowen Lists Multiple 'Best Ideas For 2022' (ABNB) (RL) (CHPT) (LNG) (SWCH) (AMZN) (IIVI) (PATH) (CFLT) (ALLO)
Nov 12, 2021 08:30AM Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences
Nov 12, 2021 08:30AM Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences
Oct 19, 2021 04:06PM Cowen Assumes Allogene (ALLO) at Outperform
May 20, 2021 08:30AM Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences
May 20, 2021 08:30AM Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences
Feb 9, 2021 08:30AM Allogene Therapeutics Announces Participation in Four Upcoming Virtual Investor Conferences
Feb 9, 2021 08:30AM Allogene Therapeutics Announces Participation in Four Upcoming Virtual Investor Conferences
Jun 2, 2020 05:50AM Allogene Therapeutics (ALLO) Prices 11.7M Share Common Offering at $47/Sh
Jun 1, 2020 09:05PM Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
Jun 1, 2020 09:05PM Allogene Therapeutics Announces Pricing of Public Offering of Common Stock
Jun 1, 2020 06:31AM Allogene Therapeutics (ALLO) Announces Proposed $450M Common Offering
Jun 1, 2020 06:30AM Allogene Therapeutics Announces Commencement of Public Offering of Common Stock
Jun 1, 2020 06:30AM Allogene Therapeutics Announces Commencement of Public Offering of Common Stock
Feb 6, 2020 08:30AM Allogene Therapeutics Announces February and March 2020 Investor Conference Schedule
Feb 6, 2020 08:30AM Allogene Therapeutics Announces February and March 2020 Investor Conference Schedule
Feb 6, 2020 08:30AM Allogene Therapeutics Announces February and March 2020 Investor Conference Schedule
Feb 5, 2019 08:00AM Allogene Therapeutics Announces February and March 2019 Investor Conference Schedule
Feb 5, 2019 08:00AM Allogene Therapeutics Announces February and March 2019 Investor Conference Schedule
Nov 5, 2018 05:35AM Cowen Starts Allogene (ALLO) at Outperform
Oct 15, 2018 04:30PM Allogene Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 11, 2018 11:13AM Allogene Therapeutics (ALLO) IPO Opens Up 22%